Cargando…
Optimised electroporation mediated DNA vaccination for treatment of prostate cancer
BACKGROUND: Immunological therapies enhance the ability of the immune system to recognise and destroy cancer cells via selective killing mechanisms. DNA vaccines have potential to activate the immune system against specific antigens, with accompanying potent immunological adjuvant effects from unmet...
Autores principales: | Ahmad, Sarfraz, Casey, Garrett, Sweeney, Paul, Tangney, Mark, O'Sullivan, Gerald C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829554/ https://www.ncbi.nlm.nih.gov/pubmed/20181099 http://dx.doi.org/10.1186/1479-0556-8-1 |
Ejemplares similares
-
DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?
por: Ahmad, Sarfraz, et al.
Publicado: (2012) -
Electroporation-Mediated DNA Vaccination
por: Fagone, Paolo, et al.
Publicado: (2010) -
Oral Tolerance to Cancer Can Be Abrogated by T Regulatory Cell Inhibition
por: Whelan, Maria C., et al.
Publicado: (2014) -
Control and Augmentation of Long-Term Plasmid Transgene Expression In Vivo in Murine Muscle Tissue and Ex Vivo in Patient Mesenchymal
Tissue
por: Morrissey, David, et al.
Publicado: (2012) -
Optimised Electroporation for Loading of Extracellular Vesicles with Doxorubicin
por: Lennaárd, Angus J., et al.
Publicado: (2021)